Oscar Health holder plans sale of 10,360 shares

Rule 144 notice covers 10,360 OSCR Class A shares from restricted stock vesting, partly to satisfy tax obligations.

Rhea-AI Filing Summary

Oscar Health, Inc. (OSCR) received a notice of proposed sale under Rule 144 for 10,360 shares of Class A common stock beneficially associated with Janet Liang. The shares have an aggregate market value of $325,829.26, compared with 273,469,000 Class A shares outstanding.

The shares relate to restricted stock vesting from the issuer as compensation, with the sale including an amount to cover a tax obligation from the settlement of a vested equity award. The notice lists an approximate sale date of September 3, 2026, with prior vesting on September 1, 2026.

Key Figures

Shares to be sold: 10,360 shares Aggregate market value: $325,829.26 Shares outstanding: 273,469,000 shares +2 more

5 metrics

Shares to be sold 10,360 shares Class A common stock proposed for sale under Rule 144

Aggregate market value $325,829.26 Market value of 10,360 Class A shares covered by the notice

Shares outstanding 273,469,000 shares Class A shares outstanding for Oscar Health, Inc.

Approximate sale date September 3, 2026 Proposed sale date for the Class A shares

Restricted stock vesting date September 1, 2026 Vesting date tied to the compensation-related shares

Key Terms

Rule 144, restricted stock vesting, vested equity award, attorney-in-fact

4 terms

Rule 144 regulatory

"See the definition of "person" in paragraph (a) of Rule 144."

Rule 144 is a U.S. securities regulation that sets conditions under which restricted or insider-held shares can be legally resold to the public, such as required holding periods, availability of public information, limits on how much can be sold at once, and certain filing requirements. For investors it matters because it determines when previously locked-up shares can enter the market — like a release valve that can increase supply, affect share price, and signal insider intent.

restricted stock vesting financial

"Class A | 09/01/2026 | Restricted Stock Vesting | Issuer"

Restricted stock vesting is the timetable and conditions under which shares granted to employees or insiders become fully owned and can be sold, typically requiring continued work or meeting performance goals. It matters to investors because large blocks of shares can become tradable at once, which can change share supply and price, and because vesting aligns insiders’ incentives with the company’s long‑term performance—think of it like a timed unlock that both rewards and locks in key people.

vested equity award financial

"resulting from the settlement of a vested equity award distribution."

attorney-in-fact regulatory

"as attorney-in-fact for Janet Liang."

An attorney-in-fact is the person or entity given legal authority through a power of attorney to act on behalf of another for specific tasks, such as signing documents, voting shares, or handling transactions. For investors, this matters because it lets a trusted representative make timely decisions or complete paperwork when the owner cannot, much like handing keys to someone to run errands on your behalf—so checks on scope and limits of that authority are important.

FAQ

What does the Form 144 filing disclose for Oscar Health, Inc. (OSCR)?

The filing discloses a proposed Rule 144 sale of 10,360 Class A shares of Oscar Health, Inc. associated with Janet Liang, arising from restricted stock vesting and including shares sold to cover a tax obligation from a vested equity award.

How many OSCR shares are proposed to be sold under this Form 144?

The notice covers a proposed sale of 10,360 shares of Oscar Health, Inc. Class A common stock. These shares are tied to restricted stock vesting and include an amount intended to cover tax obligations from settlement of a vested equity award.

What is the market value of the OSCR shares in this Rule 144 notice?

The 10,360 Class A shares referenced in the Rule 144 notice have an aggregate market value of $325,829.26. This value is reported alongside an outstanding total of 273,469,000 Class A shares of Oscar Health, Inc.

What portion of the OSCR Form 144 sale relates to taxes?

The remarks state the sale includes an amount necessary to cover a tax obligation resulting from settlement of a vested equity award. The filing does not separately quantify the exact number of shares sold specifically for the tax obligation.

When are the OSCR shares expected to vest and potentially be sold?

The filing ties the restricted stock vesting to September 1, 2026, with an approximate sale date listed as September 3, 2026 for the 10,360 Class A shares under Rule 144.

Who is involved in the OSCR Form 144 transaction and what is the broker?

The shares are for the account of Janet Liang, with the broker listed as Fidelity Brokerage Services LLC. The notice is signed by Joshua Schmitt as a duly authorized representative of Fidelity, acting as attorney-in-fact for Janet Liang.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 09/03/2026 - 03:31 PM Accepted by SEC EDGAR 09/03/2026 - 03:31 PM Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001888381
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	Oscar Health, Inc.
SEC File Number	001-40154
Address of Issuer	75 VARICK STREET 5TH FLOOR NEW YORK NEW YORK 10013
Phone	(646) 403-3677
Name of Person for Whose Account the Securities are To Be Sold	Liang Janet
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Class A	Fidelity Brokerage Services LLC 900 Salem Street Smithfield RI 02917	10360	325829.26	273469000	09/03/2026	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Class A	09/01/2026	Restricted Stock Vesting	Issuer			10360	09/01/2026	Compensation

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks	Sale includes an amount necessary to cover a tax obligation resulting from the settlement of a vested equity award distribution.
Date of Notice	09/03/2026
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ Joshua Schmitt, as a duly authorized representative of Fidelity Brokerage Services LLC, as attorney-in-fact for Janet Liang.
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)